Jin, Huiling
Fujita, Takayuki
Jin, Meihua
Kurotani, Reiko
Hidaka, Yuko
Cai, Wenqian
Suita, Kenji
Prajapati, Rajesh
Liang, Chen
Ohnuki, Yoshiki
Mototani, Yasumasa
Umemura, Masanari
Yokoyama, Utako
Sato, Motohiko
Okumura, Satoshi
Ishikawa, Yoshihiro
Funding for this research was provided by:
Japan Society for the Promotion of Science (25460296)
Japan Society for the Promotion of Science (16K08501)
Japan Society for the Promotion of Science (23591087)
Japan Society for the Promotion of Science (16H05300)
Japan Society for the Promotion of Science (16K15205)
Ministry of Education, Culture, Sports, Science, and Technology (22136009)
Ministry of Education, Culture, Sports, Science, and Technology (S1511018)
Japan Agency for Medical Research and Development (66890005)
Japan Agency for Medical Research and Development (66890011)
Japan Agency for Medical Research and Development (66890001)
Japan Agency for Medical Research and Development (66890023)
Grant for Strategic Research Promotion of Yokohama City University (S2501)
Grant for Strategic Research Promotion of Yokohama City University (S2501)
the Naito Foundation
Senshin Medical Research Foundation
Academic Contribution from Pfizer Japan
the Research Foundation for Community Medicine
This article is maintained by: Elsevier
Article Title: Epac activation inhibits IL-6-induced cardiac myocyte dysfunction
Journal Title: The Journal of Physiological Sciences
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s12576-016-0509-5
Content Type: article
Copyright: Copyright © 2016 The Author(s) 2016. corrected publication 2019. Published by Elsevier Inc.